高血压的性别差异:共识文件解读
该共识文件全面综述了原发性高血压在性别差异方面的现有知识,涵盖血压终生变化、高血压发展、病理生理机制、与心血管危险因素的交互作用、心脏和动脉的靶器官损害、心血管疾病影响及降压治疗效果的差异。文件指出女性心血管疾病风险在较低血压水平即升高,但缺乏专门设计临床试验数据,尚不确定是否应区别管理女性与男性高血压。
要点
- 女性心血管风险在较低血压水平即升高,性别特异性诊断阈值可能合理。
- 缺乏专门临床试验数据,尚不确定是否应区别管理女性与男性高血压。
- 共识强调需聚焦研究以推进性别特异性高血压预防和管理。
核心结论
- 性染色体和性激素对女性和男性原发性高血压的血压调节及心血管危险因素分布影响不同。
- 女性心血管疾病风险在较低血压水平即升高,性别特异性诊断阈值可能合理。
- 因缺乏数据,尚不确定高血压管理(包括治疗目标、药物选择及剂量)是否应性别差异化。
研究设计与样本
- 该文件为共识文件,旨在全面综述当前关于原发性高血压性别差异的知识。
主要发现
- 女性心血管疾病风险在较低血压水平即升高。
- 缺乏专门设计的临床试验数据,尤其关于高血压管理性别差异。
临床怎么用
- 临床应关注女性在较低血压水平即升高的心血管风险。
- 目前尚不确定是否应基于性别差异调整高血压治疗目标、药物选择及剂量。
局限性
- 缺乏专门设计的临床试验数据,尤其关于高血压管理的性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities differentially in females and males with essential arterial hypertension. The risk for CV disease increases at a lower BP level in females than in males, suggesting that sex-specific thresholds for diagnosis of hypertension may be reasonable. However, due to paucity of data, in particularly from specifically designed clinical trials, it is not yet known whether hypertension should be differently managed in females and males, including treatment goals and choice and dosages of antihypertensive drugs. Accordingly, this consensus document was conceived to provide a comprehensive overview of current knowledge on sex differences in essential hypertension including BP development over the life course, development of hypertension, pathophysiologic mechanisms regulating BP, interaction of BP with CV risk factors and co-morbidities, hypertension-mediated organ damage in the heart and the arteries, impact on incident CV disease, and differences in the effect of antihypertensive treatment. The consensus document also highlights areas where focused research is needed to advance sex-specific prevention and management of hypertension.
引用
- Gerdts E, Sudano I, Brouwers S, et al. Sex differences in arterial hypertension. Eur Heart J. 2022. PMID: 36136303. doi:10.1093/eurheartj/ehac470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。